Direct thyroid hormone signalling via ADP-ribosylation controls mitochondrial nucleotide transport and membrane leakiness by changing the conformation of the adenine nucleotide transporter  by Mowbray, John & Hardy, D.Louise
FEBS 17527 FEBS Letters 394 (1996) 61 65 
Direct thyroid hormone signalling via ADP-ribosylation controls 
mitochondrial nucleotide transport and membrane leakiness by changing 
the conformation of the adenine nucleotide transporter 
John Mowbray*, D. Louise Hardy 
Regulatory Mechanisms and Signalling Group, Department of Biochemistry and Molecular Biology, University College London, Gower Street, 
London WC1E 6BT, UK 
Received 22 July 1996 
Abstract Addition of triiodothyronine at 10 pM in vitro to 
hypothyroid rat liver mitochondria doubles the rate of the 
adenine nucleotide transporter at low ADP concentrations. 
Nicotinamide abolishes this effect in parallel with its inhibition 
of the ADP-ribosylation of an inner membrane protein identical 
in size to the transporter. Nieotinamide also renders euthyroid 
preparations indistinguishable from hypothyroid ones. A mech- 
anism is offered to explain these findings in which it is proposed 
that the adenine nucleotide transporter is a true allosteric protein 
and that its covalent modification by ADP-ribosylation increases 
the stability of the less favoured externally-facing C-conforma- 
tion and thus increases the proportion of transporters in this 
orientation: although the C-conformation is significantly more 
leaky to cations than the tight matrix-facing M-conformation, 
this enhances ADP import. This model is shown to offer an 
explanation not only for the transport effects of T3 but also for 
those of oxidative stress and ADP-ribosylation inhibitors on 
Ca 2+, H ÷ and K + transfer across the mitochondrial inner 
membrane. Ca 2+ at 30 nM appears to stabilize the M- 
conformation of the transporter by a mechanism other than 
ADP-ribosylation. 
Key words: Adenine nucleotide transport; ADP-ribosylation; 
C/M-conformation of transporter; Calcium; H+/K + leak; 
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1. Introduction 
Although early work proposing a direct interaction of thyr- 
oid hormones with mitochondria s now regarded as uncertain 
or unphysiological, in recent years evidence has begun to ac- 
cumulate that triiodothyronine (T3), in addition to longer- 
term effects exerted through transcription and translation, 
can indeed elicit a very rapid response from mitochondria. 
For example, mitochondria very rapidly and preferentially 
acquire T3 administered in vivo [1,2] and saturable T3 tight- 
binding sites have been reported in inner mitochondrial mem- 
branes only from tissues which respond to thyroid hormone 
[3]. To complement this evidence of a putative receptor, rapid 
effects of hormone on an energy-driven mitochondrial process 
such as respiratory control, uncoupler sensitivity [2] and cal- 
cium transport [4] have been observed. In our laboratory we 
have found that liver mitochondria from thyroidectomized 
rats show a number of altered responses to ADP stimulation 
that hormone addition at near-physiological concentrations 
both in vivo and in vitro can restore to normal within 15 
min [1,5-8]. 
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A striking feature of the assay of mitochondria in relatively 
low protein medium is that they responded to T3 at concen- 
trations as low as 10 -13 M [8]. The possibility that some signal 
amplification mechanism involving covalent modification of 
mitochondrial proteins could be present was therefore xam- 
ined. While no change in protein phosphorylation could be 
detected, nicotinamide, an inhibitor of mitochondrial mono- 
ADP ribosylation, abolished the T3 effect on the phosphory- 
lation of ADP by hypothyroid liver mitochondria [9]. More- 
over, incubation with nicotinamide mimicked the effects of 
thyroid ablation in euthyroid liver mitochondria nd mito- 
plasts; and these could be reversed by washing out the nico- 
tinamide followed by T3 addition [9]. 
We have shown that, in parallel with activity changes, T3 in 
vitro rapidly stimulates the incorporation of radioactivity 
from extra-mitochondrial [14C-adenine]-NAD ~ into inner 
membrane proteins in intact mitoplasts and in mitochondria 
and that this stimulation too is abolished by nicotinamide 
[10]. On polyacrylamide g l electrophoresis under acid condi- 
tions we reported without presenting any data that the incor- 
porated radioactivity migrates as a single band with an appar- 
ent molecular mass of about 30 kDa. This was consistent with 
the reports from other laboratories of ADP-ribosylation of a 
30 kDa inner membrane protein in liver sub-mitochondrial 
particles [11,12] although somewhat strangely this is proposed 
to result from NAD + hydrolysis and then very selective non- 
specific labelling by the ADP-ribosyl moiety [13,12]. An inner 
membrane protein of this size, the adenine nucleotide trans- 
porter (ANT) [14], has long been suggested as a mitochondrial 
target for thyroid hormones [15] and we had reported pre- 
viously that the velocity of the ANT was halved in hypothyr- 
oid mitochondria because of a 2.2-fold increase in the appar- 
ent Km and subject o restoration within 15 min by hormone 
in vivo [5]. However, we had found that in vitro incorporation 
of labelled NAD + into the 30 kDa species was abolished by 
T3 [10] which we initially interpreted as providing no support 
for this protein as a target for T3 signalling involving ADP- 
ribosylation. Here we reconsider this conclusion and demon- 
strate that the velocity of the ANT can be reduced by more 
than half by nicotinamide addition to isolated mitochondria: 
further, addition of T3 at 10 pM restored the rate to normal 
and this was abolished by concomitant addition of nicotin- 
amide. We go on to propose a model based on alteration of 
the relative proportions of the two distinct conformations of 
the ANT (see [16]) by ADP-ribosylation which may offer a 
molecular mechanism not only for the transport effects of T~ 
but also for those of oxidative stress and ADP-ribosylation 
inhibitors on Ca 2+ [17-20], H + [21,22], and K + [22-24] trans- 
fer across the mitochondrial inner membrane. 
All rights reserved. 
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2. Materials and methods 
2.1. Animals and mitochondria 
Male rats (130-150 g) of a Sprague-Dawley strain bred in the 
College were rendered hypothyroid either by thyroidectomy and 
then maintained on a calcium lactate supplemented diet as in [1] or 
supplied with water containing 6-n-propyl-2-thiouracil as in [10] and 
used after 6 weeks when their weight had stabilised at about 200 g. 
Liver mitochondria were prepared as in [10] and mitoplasts prepared 
from these by removing the outer membrane as detailed in [9]. Hor- 
mone was administered in vivo via the tongue veins 15 min before 
sacrifice [1] and in vitro as set out in [8]. Protein was measured as in 
[lO]. 
2.2. Oxygen electrode and adenine nucleotide transport measurements 
Oxygen electrode measurements were carried out in 130 mM KC1/2 
mM MgCI2/2 mM EGTA/5 mM Tris-HC1 buffer at 37°C as detailed 
in [10]. Adenine nucleotide transport was measured using the integral 
form of the transport equations as set out in [5], except hat the buffer 
used was the same as for the oxygen electrode xperiments. In some 
experiments CaC12 was added to give a final buffered concentration f 
30 nM (see [8]). 
2.3. Incubation with labelled NAD + and LDSIPAGE 
Incubations with [UJaC]adenine-labelled NAD + were carried out 
exactly as detailed in [10]. After incubation the mitoplasts were pel- 
leted in an Eppendorf microfuge and resuspended at 2 mg/ml in 8 M 
urea/0.25 M citric acid/0.031 M phosphoric acid/5% (w/v) LDS/4% (v! 
v) 2-mercaptoethanol (pH 4.0). The pelleted mitoplasts were separated 
into membrane and matrix fractions by disrupting them by freezing 
and thawing followed by recentrifugation to pellet the membranes. 
The resultant supernatant (matrix) fraction was denatured by addition 
of the urea/LDS buffer to give a final protein concentration of 2 mg/ 
ml. A 10% acrylamide gel at pH 4 was prepared by the method of 
Jones et al. [27] and run for 14 h at 20 V in 93.8 mM citric acid/12.4 
mM HaPO4/I% LDS (pH 4.0) buffer. The gel was stained in 42% 
methanol/16% acetic acid/0.12% (w/v) Kenacid Blue and destained 
in 10% methanol/2% acetic acid before measurement of radioactive 
incorporation. 
2.4. Materials" 
Nicotinamide-[U-14C]adenine d ucleotide ammonium salt (270 Ci/ 
mol) and [8-14C]ADP (52 and 57.1 Ci/mol) were purchased from ICN 
and NEN respectively. All other materials obtained as described in 
[8 10]. 
3. Results and discussion 
3.1. The effect o f  thyroid hormone and Ca 2+ ions on the rate o f  
the adenine nucleotide transporter 
We have shown that the rate of exchange catalysed by an 
obligatory antiport could be described by an integral form of 
the rate equations which dispenses with the need to maintain 
Table 1 
The effects of thyroidectomy and medium ADP concentration on 
the rate of the adenine nucleotide transporter 
Condition n Transport rate (nmol-min-l.mg <)  
at 2 /aM ADP at 20 BM ADP 
Normal 5 1.83 + 0.02 3.44 _+ 0.46 
Thyroidectomized 5 0.97 + 0.08* 3.22 + 0.14 
Thyroidectomized- 
T3 injected 4 1.91 + 0.25 3.57 + 0.63 
The values are means + S.E.M. of n mitochondrial preparations. The 
rates were derived from the best straight lines fitted to plots of 
Ln(Rm~-Rm) vs. time (see Section 2 [5]) for initial ADP concentra- 
tions of either 2 /aM (3.5 Ci/mol) or 20 ~M (0.35 Q/mo0. T.~ was 
administered 15 min prior to sacrifice via the tongue veins (at 1 nmol/ 
100 g body weight) to rats thyroidectomized 6 weeks previously. 
*P < 0.005 vs. normals. 
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Fig. 1. LDS/PAGE of mitop]ast and matrix proteins. The upper pa- 
nel shows a photograph of the gels stained for protein after incuba- 
tion with [U-UC]adenJne-NAD + in the absence or presence of 1 nM 
T~ or 1 nM T~ plus 20 mM nicotinamide as indicated. The lower 
panel shows the incorporation of radioactivity into each 5-ram sec- 
tion of a gel incubated in the absence of either nicotinamide or  T3 .  
The distances of molecular-mass standard proteins are shown and 
the arrow indicates where a 55-kDa protein would be expected to 
run .  
near-constant external substrate concentrations [5]. It is thus 
possible to measure transport rates at low substrate concen- 
trations without the need to have large volumes of suspending 
fluid. We showed that thyroid deficiency led to an increase in 
the apparent Km of the ANT of rat liver mitochondria from 
the euthyroid value of 2.8 ~M to 6.3 p.M and that this was 
returned to normal 15 rain after a near-physiological intrave- 
nous dose of T3 [5]. Increases in the ANT transport  rate at 
longer times after thyroid hormone administrat ion reported 
by others [25,26] probably reflect an increased number  of 
transporters in the membranes. The data shown in Table 1 
demonstrate that, in agreement with these earlier findings, the 
highly significant decrease in the transport  rate in hypothyroid 
preparations observed at a concentration of ADP near to the 
Km is not detectable at a much higher concentration. The 
administrat ion of T3 in vivo confirms the previous finding 
[5] that this is a rapidly reversible ffect of thyroid hormone 
depletion. 
Table 2 shows that the in vivo effect of T3 on the transport 
of 2.5/aM ADP by the ANT can be reproduced by the in vitro 
addition of 10 pM hormone to isolated liver mitochondria 
prepared from hypothyroid animals. This doubl ing of the 
ANT transport rate in response to T3 was abolished in the 
presence of nicotinamide: furthermore, the addition of nico- 
t inamide led not only to a significant decrease in the transport  
rate in all conditions, it also rendered euthyroid preparations 
indistinguishable from hypothyroid ones. If this action of ni- 
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Table 2 
The effects of hypothyroidism, T3 addition in vitro, and the presence of medium Ca 2+ and nicotinamide on the rate of the adenine nucleotide 
transporter 
Additions Transport rate (nmol.min-l-mg -~) 
(n) Normals (n) Hypothyroid (n) Hypothyroid+T:~ 
none (7) 2.15 + 0.16 (6) 1.12 + 0.07 h (6) 1.97 _+ 0.18 
+nic. (7) 0.86 -+ 0.09 af (6) 0.81 + 0.09 df (6) 0.93 -+ 0.13 ~g 
+Ca 2+ (10) 1.26 + 0. l 3 ~* (8) 0.76 + 0.07 hf (8) 1.21 + 0.12 ~'~ 
+Ca 2+ +nic. (10) 0.51 + 0.04 ~ (8) 0.46 + 0.04 a (8) 0.62 +_ 0.08 a 
The rates, derived as in Table 1, are means + S.E.M. of n mitochondrial preparations. The initial medium ADP concentration was 2.46 gM (10-30 
Ci/mol). When present, he medium concentration f (buffered) Ca 2+ was 30 nM, of nicotinamide (nic.) 10 mM and of T3, l0 pM. Hypothyroidism 
was induced by propylthiouracil administration (see Section 2). Significance testing: medium additions vs. none: P < 0.0005~; < 0.0051'; < 0.01c; 
< 0.025 d; vs. Ca 2+ +nicotinamide: P < 0.0005 e ; < 0.005 f ; < 0.05g ; hypothyroid vs. normal: P < 0.0005 h. 
cotinamide is related to its inhibition of ADP-ribosylation of 
an inner membrane protein (see below), the finding that nico- 
tinamide decreased further the rate in the hypothyroid prep- 
arations (Table 2) implies that there still remains some cova- 
lently modified protein in propylthiouracil-treated 
preparations. 
This impairment of normal mitochondria by nicotinamide 
parallels that reported earlier [9] for measurements of the 
apparent ADP/O ratio at low protein concentrations. In these 
earlier studies [8,9], we had shown that in order to observe the 
maximum decrease in ADP/O ratio in hypothyroid prepara- 
tions, the free Ca 2+ ion concentration i the extramitochon- 
drial medium had to be above 25 nM; Ca 2+ ion concentra- 
tions as low as this had no effect on euthyroid preparations 
[8]. We thus measured the effect on the ANT of adding Ca 2+ 
buffered at 30 nM. Table 2 shows that Ca 2+ even at this low 
concentration decreases the ANT transport rate by 40%. The 
mechanism of the calcium inhibition may, however, be sepa- 
rate from that by which nicotinamide acts since, when mito- 
chondria in all three conditions were rendered equivalent by 
nicotinamide addition, Ca 2+ still produced a further 40% in- 
hibition (Table 2). The concentration of free Mg 2+ ions, which 
have been found to increase the apparent Kn~ of the ANT 
[28,5] since the transporter substrates are the free nucleotides, 
only increases by 1.25% from 1.74 mM on the addition of 
Ca 2+ ions and thus seems unlikely to provide an explanation 
for the inhibitory effect. 
3.2. ADP-ribosylation of inner membrane proteins and the 
effect of nicotinamide and Ta 
Mitoplasts shown to be coupled by an oxygen electrode 
experiment, and therefore intact, were pre-incubated for 10 
min at 37°C with [UJ4C]adenine-labelled NAD + and then 
for a further 8 min in the presence or absence of T3 or T3 
plus nicotinamide as detailed in Section 2. After removal of 
the incubation buffer, the membrane proteins and matrix pro- 
teins were separated on lithium dodecyl sulfate polyacryl- 
amide gel electrophoresis, tained and 5-mm slices of the 
gels assayed for radioactivity (see Section 2 for details). 
Fig. I shows a photograph of the stained gels from such an 
experiment together with the radioactivity profile obtained in 
the absence of Ta or nicotinamide. The only ADP-ribosylated 
proteins migrate with an apparent molecular mass of around 
30 kDa in agreement with the findings reported from two 
other labs [11,13]. Although, as might have been expected, 
the labelling in this band was abolished by adding the 
ADP-ribosylation inhibitor nicotinamide, it was also unex- 
pectedly abolished by adding T3 alone (radioactivity profiles 
not shown). This not unreasonably caused us initially to dis- 
card this as evidence for T3 stimulated ADP-ribosylation. 
However, an alternative interpretation can be offered which 
implies the opposite of this original conclusion. In the label- 
ling experiment, he radioactive NAD + was added externally 
to the intact mitoplasts and NAD + has long been known to 
cross the mitochondrial membrane very slowly [29]. That 
there was no significant entry of the label during the course 
of the experiment is supported by our finding no evidence of 
labelling of the soluble matrix protein of around 50 kDa (see 
arrow, Fig. 1), which Hilz et al. [13] found in broken mito- 
chondrial preparations, although there are unlabelled matrix 
proteins migrating in this region (Fig. 1). Thus the label in- 
corporated into the 30 kDa membrane protein would have 
been from the outside of the inner membrane. In a similar 
experiment, Richter et al. [11] used sonicated mitoplasts and, 
although there is no indication what proportion of their ves- 
icles were closed, it may be presumed that their labelling of 
the 30 kDa protein would have been mainly at the inside face 
of the inner membrane. Moreover, they demonstrated in a 
dual labelling experiment [11] that there was rapid turnover 
of the covalent label attached to the protein. ADP-ribosyla- 
tion sites accessible from both sides of the membrane would 
be consistent with the double dimeric or tetrameric organisa- 
tion of the ANT [16]. A T3-stimulated ADP-ribosyl transfer 
using as substrate unlabelled matrix NAD + (as it was in our 
experiments) might be expected to alter the transporter con- 
formation and thus the accessibility of external sites to ADP- 
ribosylation. Consonant with the matrix being the source of 
the NAD + are the observations that in hypothyroidism the 
mitochondrial content of both nicotinamide nucleotides 
(NAD + Kinase is a mitochondrial enzyme) have been found 
Table 3 
Factors influencing the two stable conformations of the mitochon- 
drial adenine nucleotide tranporter 
Properties Promoted by 
M-conformation NEM-sensitive ADP; Bonkrekate 
low Ca 2+ leak ADP-ribosylation 
inhibitors 
low H+/K + leak hypothyroidism 
slow ADP transport low external [Ca 2+] 
C-conformation NEM-insensitive ATP; Atractylate 
increased Ca 2+ leak ADP-ribosylation 
increased H+/K + leak triiodothyronine 
increased ADP high matrix [NAD +] 
transport 
See text Section 3.3 for discussion and references. 
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to increase significantly and conversely to decrease in hy- 
perthyroidism [6,30,31]. In this view T3 stimulation along 
with rapid turnover would lead to the apparent inhibition of 
incorporation from external labelled-NAD +. 
3.3. A covalently modified two-state model of the adenine 
nucleotide transporter and its consequences 
It is well accepted that the mitochondrial ANT can exist in 
two distinct protein conformations which are differentially 
sensitive to thiol inhibitors [32,18] and to proteases [33]. 
They can be interconverted by the use of inhibitors [34]; 
atractylate induces the C-confirmation i which the nucleotide 
binding site faces the external mitochondrial environment and 
Bonkrekate induces the M-conformation in which the site 
faces the matrix. 
Although these stable conformations are interconverted by 
binding ADP 3- and ATP 4- (see [16]), if it is presumed that 
the ANT is a true example of the Monod-Wyman-Changeux 
allosteric theory [35] then, like the nicotinic acetylcholine r - 
ceptor [36], it would be expected to show clear switching be- 
tween conformational states with or without ligand binding. 
Our hypothesis i that (1) the M-conformation is the preferred 
or more stable conformation which, as a tighter or less leaky 
state (see below) of the transmembrane protein, better pro- 
tects the intramitochondrial environment: it is, however, less 
advantageous in transporting ADP from the intermembrane 
space which requires the C-conformation. 
(2) Covalent modification of the ANT by ADP-ribosylation 
increases the stability of the C-conformation and hence the 
proportion of transporters and their residence time in that 
state: although this increases membrane leakiness, especially 
in the absence of substrate, it has clear advantages for ADP 
import. 
Thus in the findings reported here, the hypothyroid prep- 
arations have a smaller fraction of the ANT in the externally 
oriented state and so show impaired ADP import which can 
be overcome by using higher concentrations of substrate so 
that the increased generation and export of ATP augments the 
number of transporters in the C-conformation. 
(3) The mechanism proposed for the action of T3 is that it 
activates an ADP-ribosyl transferase (possibly by increasing 
its affinity for free matrix NAD+; see below) which, by cova- 
lently modifying the ANT, increases the number of transpor- 
ters in the C-conformation. Nicotinamide reverses this cova- 
lent modification and so leads to fewer externally available 
transporter sites. This model accords with findings from a 
number of different mitochondrial studies. 
In support of the proposal that hypothyroidism leads to a 
decreased proportion of ANT in the C-conformation is the 
finding that investigation of the kinetics of liver mitochondrial 
ANT found that thyroidectomy led to half maximal inhibition 
of the transporter at lower concentrations of atractylate (C- 
conformation inhibitor) and higher concentrations of bongk- 
rekate (M-conformation i hibitor) than in controls [37]. Also 
hypothyroid mitochondria show lower H + [21] and K + [38] 
permeability, whereas the C-conformation of the ANT has 
been found to promote increased permeability of the inner 
membrane to K + and H + [22,23]; moreover, the decreased 
permeability in hypothyroid preparations can be rapidly re- 
versed by a single dose of T3 [21] which points to a" mechan- 
ism separate from alteration of membrane lipids [39]. Conver- 
sion of ANT to the C-conformation has also been shown to 
promote rapid loss of Ca 2+ from pre-loaded mitochondria [18] 
and to increase 1 ~tM Ca 2+ uptake [24]. Of relevance in this 
context is the observation that T3 induces calcium influx into 
liver cells within minutes and increases respiration and gluco- 
neogenesis with the same kinetics leading to the proposal that, 
as with glucagon, the signalling involves increased mitochon- 
drial uptake of cytosolic Ca 2+ [40]. 
Several studies also support the link between ADP-ribosy- 
lation, the conformation of the ANT and ion leakage across 
the mitochondrial membrane. Hydroperoxides and quinones 
which cause rapid and extensive oxidation of mitochondrial 
pyridine nucleotides have been observed to cause Ca 2+ release 
from rat liver mitochondria [17,20]. This efflux was accompa- 
nied by the hydrolysis of NAD + to release nicotinamide and 
could be prevented by added nicotinamide in one study [17] 
and by the more specific ADP-ribosylation inhibitor m-iodo- 
benzylguanidine in the other [19,20]. In the context of the 
model proposed above, these suggest hat the extensive in- 
crease in matrix NAD + concentrations promotes ADP-ribo- 
sylation of ANT and its conversion to the leaky C-conforma- 
tion. In agreement with this, extensive oxidation of 
mitochondrial NAD + by incubation with acetoacetate which 
led to increased Ca 2+ leakiness was also shown to increase the 
proportion of ANT in the C-conformation [18]. 
The nature of the observed ADP-ribosyl transfer to the 
inner membrane 30 kDa protein is somewhat controversial 
since two groups [13,12] have provided evidence that this ap- 
pears to be a very specific non-enzymic covalent modification 
by ADP-ribose released by an NAD + glycohydrolase. How- 
ever, a more recent study has suggested that all NAD + gly- 
cohydrolase activity in rat liver mitochondria is absent from 
the matrix and associated with the outer membrane [41], Thus 
it may be that the intramitochondrial enzyme readily reverses 
the covalent modification and exchanges the ADP-ribosyl en- 
tity with free ADP-ribose. 
Finally our observation that adding Ca 2+ ions at the lower 
end of the resting physiological range impairs 2 ~tM ADP 
transport whether or not nicotinamide is present appears to 
suggest that these too may promote the M-conformation 
though not by altering ADP-ribosylation. 
These findings and their proposed action in influencing the 
two conformations of ANT are summarized in Table 3. It 
remains to be shown by direct experiment that the 30 kDa 
protein ADP-ribosylated in response to T3 is indeed identical 
to the adenine nucleotide transporter: and that T3 stimulates 
this ADP-ribosylation using the matrix pool of NAD + as 
substrate. 
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